Erin Pleasance

14.3k total citations
41 papers, 1.1k citations indexed

About

Erin Pleasance is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Erin Pleasance has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 18 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Erin Pleasance's work include Cancer Genomics and Diagnostics (18 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Genetic factors in colorectal cancer (5 papers). Erin Pleasance is often cited by papers focused on Cancer Genomics and Diagnostics (18 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Genetic factors in colorectal cancer (5 papers). Erin Pleasance collaborates with scholars based in Canada, United States and United Kingdom. Erin Pleasance's co-authors include Steven J.M. Jones, Marco A. Marra, Michael R. Stratton, Peter J. Campbell, George Follows, P. Andy Futreal, Ed Dicks, Ian Goodhead, Anthony R. Green and Richard Rance and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Erin Pleasance

36 papers receiving 1.1k citations

Peers

Erin Pleasance

GENET

ONCOL

PFM

Doruk Beyter Iceland

Adam P. Butler United Kingdom

Lőrinc Sándor Pongor United States

Peyton Greenside United States

Anne‐Katrin Emde United States

Silvana Debernardi United Kingdom

Daniel Bottomly United States

Anna Vähärautio Finland

Markus J. van Roosmalen Netherlands

Doruk Beyter Iceland

Erin Pleasance

549 ×0.8

330 ×0.9

246 ×1.2

GENET

174 ×0.9

ONCOL

110 ×0.9

PFM

Citations per year, relative to Erin Pleasance Erin Pleasance (= 1×) peers Doruk Beyter

Countries citing papers authored by Erin Pleasance

Since Specialization

Citations

This map shows the geographic impact of Erin Pleasance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Pleasance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Pleasance more than expected).

Fields of papers citing papers by Erin Pleasance

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Pleasance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Pleasance. The network helps show where Erin Pleasance may publish in the future.

Co-authorship network of co-authors of Erin Pleasance

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Pleasance. A scholar is included among the top collaborators of Erin Pleasance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Pleasance. Erin Pleasance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paulin, Luis F., et al.. (2025). Closing the gaps, and improving somatic structural variant analysis and benchmarking using CHM13-T2T. Genome Research. 35(4). 621–631. 1 indexed citations

Titmuss, Emma, Irene Yu, Erin Pleasance, et al.. (2024). Exploration of Germline Correlates and Risk of Immune-Related Adverse Events in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors. Current Oncology. 31(4). 1865–1875. 1 indexed citations

Pleasance, Erin, Alessia Gagliardi, Christopher S. Hughes, et al.. (2024). Mapping in silico genetic networks of the KMT2D tumour suppressor gene to uncover novel functional associations and cancer cell vulnerabilities. Genome Medicine. 16(1). 136–136. 1 indexed citations

Culibrk, Luka, Jasleen Grewal, Erin Pleasance, et al.. (2024). Robust Somatic Copy Number Estimation using Coarse-to-fine Segmentation. Current Bioinformatics. 20(9). 789–803.

Feng, Xiaolan, Laurie Tonon, Haocheng Li, et al.. (2023). Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with “Hot” Tumor Immune Microenvironment. Cancers. 15(14). 3705–3705. 6 indexed citations

Tsang, Erica S., Veronika Csizmók, Laura M. Williamson, et al.. (2023). Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration. npj Precision Oncology. 7(1). 31–31. 11 indexed citations

Titmuss, Emma, Alexandra Pender, James T. Topham, et al.. (2022). The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space. Journal of Molecular Diagnostics. 24(6). 609–618. 7 indexed citations

Pleasance, Erin, et al.. (2022). A p53 transcriptional signature in primary and metastatic cancers derived using machine learning. Frontiers in Genetics. 13. 987238–987238. 4 indexed citations

Titmuss, Emma, Richard Corbett, Scott Davidson, et al.. (2022). TMBur: a distributable tumor mutation burden approach for whole genome sequencing. BMC Medical Genomics. 15(1). 190–190. 4 indexed citations

10.

Zhang, Yiqun, Fengju Chen, Erin Pleasance, et al.. (2021). Rearrangement-mediated cis-regulatory alterations in advanced patient tumors reveal interactions with therapy. Cell Reports. 37(7). 110023–110023. 13 indexed citations

11.

Majounie, Elisa, Kathleen Wee, Laura Williamson, et al.. (2019). Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variant. Molecular Case Studies. 6(1). a004713–a004713. 6 indexed citations

12.

Wong, Derek, Yaoqing Shen, Adrian Levine, et al.. (2019). The pivotal role of sampling recurrent tumors in the precision care of patients with tumors of the central nervous system. Molecular Case Studies. 5(4). a004143–a004143. 3 indexed citations

13.

Lacambra, Maribel D., Herbert H. Loong, Ka‐Fai To, et al.. (2018). FUS-NFATc2 sarcoma of bone, a novel molecular entity with aggressive behavior: Clinical and molecular pathology findings of two cases. Annals of Oncology. 29. ix125–ix125. 1 indexed citations

14.

Pleasance, Erin, Jasleen Grewal, Eric Y. Stutheit-Zhao, et al.. (2018). Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making. Molecular Case Studies. 4(2). a002626–a002626. 18 indexed citations

15.

Tsang, Erica S., Yaoqing Shen, Cheryl Ho, et al.. (2018). Clinical outcomes after whole-genome sequencing in patients with metastatic non-small-cell lung cancer. Molecular Case Studies. 5(1). a002659–a002659. 3 indexed citations

16.

Sheffield, Brandon S., Anna V. Tinker, Yaoqing Shen, et al.. (2015). Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing. PLoS ONE. 10(3). e0119689–e0119689. 26 indexed citations

17.

Greenman, Chris, Erin Pleasance, Scott Newman, et al.. (2011). Estimation of rearrangement phylogeny for cancer genomes. Genome Research. 22(2). 346–361. 75 indexed citations

18.

Pleasance, Erin, Nigel J. O’Neil, Allan K. Mah, et al.. (2007). Identification and analysis of internal promoters in Caenorhabditis elegans operons. Genome Research. 17(10). 1478–1485. 39 indexed citations

19.

Gorski, Sharon M., Suganthi Chittaranjan, Erin Pleasance, et al.. (2003). A SAGE Approach to Discovery of Genes Involved in Autophagic Cell Death. Current Biology. 13(4). 358–363. 169 indexed citations

20.

Pleasance, Erin, Marco A. Marra, & Steven J.M. Jones. (2003). Assessment of SAGE in Transcript Identification. Genome Research. 13(6a). 1203–1215. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact